This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

About Diabetes » Treatments

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Antibodies Hold Keys to Diabetes Breakthrough

Posted: Wednesday, December 28, 2011

A new diabetes study in the US is developing a diabetes treatment that could help tackle the disease, and not just the symptoms.

Research Finds That Patients with Diabetes Should Take More Vitamin B12 Daily

Posted: Monday, December 26, 2011

People who have type 2 diabetes and are taking metformin should take more than the recommended daily allowance of vitamin B12.

Omega-3 Use Shows Diabetes Benefits

Posted: Monday, November 07, 2011

A new study has found that omega-3 fatty acids, better known as fish oil, may help to protect against chronic inflammation and insulin resistance.

Drinking Less than 17 Ounces of Water a Day Can Impact Blood Sugars

Posted: Tuesday, November 01, 2011

People who drink less than a couple of glasses of water each day may be more likely to develop abnormally high blood sugar.

FDA Approves Diabetes and Cholesterol-Lowering Drug Combo: Juvisync®

Posted: Sunday, October 09, 2011

Known as Juvisync (Merck), the new medication combines sitagliptin (Januvia, Merck), a dipeptidyl peptidase-4 (DPP-4) inhibitor used for glycemia control, with the cholesterol-lowering simvastatin.

New First in Class Glucagon Antagonists Show Promise for Diabetes

Posted: Sunday, September 25, 2011

New data on two investigational glucagon receptor antagonists suggest that this novel class of drugs has potential to be an effective treatment for type 2 diabetes.

Intensified Treatment with Basal Insulin Improves Control and Weight Loss

Posted: Saturday, September 24, 2011

Adding insulin detemir to a treatment regimen of metformin and liraglutide improved glycemic control and led to sustained weight loss for up to 52 weeks in patients with type 2 diabetes.

EASD: Outpatient Test Discriminates MODY from Type 1 Diabetes

Posted: Saturday, September 24, 2011

A measure of the postprandial ratio of urinary C-peptide to creatinine (UCPCR) can distinguish maturity-onset diabetes of the young (MODY) from type 1 diabetes mellitus, allowing some children who would otherwise be treated with insulin to receive oral antidiabetic agents alone.

EASD: Twice-Daily Aspirin Betters Platelet Inhibition for People with Diabetes

Posted: Monday, September 19, 2011

Twice-daily aspirin administration, but not a once-daily doubling of the dose, appears to provide good inhibition of platelet cyclooxygenase (COX)-1 in diabetic patients who have rapid recovery of COX-1 activity, and might enhance cardiovascular protection.

EASD: First Injection-free Once-A-Year GLP-1

Posted: Sunday, September 18, 2011

ITCA 650, injection-free continuous delivery of GLP-1 therapy, demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI AEs typically associated with this class.